• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Andra medicinska specialiteter
    3. Farmakologi

    Design of Hybrid Molecules for Drug Development

    AvMichael Decker

    Häftad, Engelska, 2017

    1 868 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Beginning with an introduction to hybrid molecule design and background as to their need, the book goes on to explore a range of important hybrids, with hybrids containing natural products, molecules containing NO- and H2S-donors, dual-acting compounds acting as receptor ligands and enzyme inhibitors, and the design of photoresponsive drugs all discussed.

    Drawing on practical case studies, the hybridization of molecules for development as treatments for a number of key diseases is then outlined, including the design of hybrids for Alzheimer's, cancer, and malaria.

    With its cutting-edge reviews of breaking developments in this exciting field, the book offers a novel approach for all those working in the design, development, and administration of drugs for a range of debilitating disorders.



    • Highlights an approach unimpaired by the limitations of the classical search for lead structures - one of the core problems in modern drug development processes, making the content of high relevance for both academic and non-academic drug development processes
    • Pulls together research and design techniques in a novel way to give researchers the best possible platform from which to review the approaches and techniques applied
    • Compares the advantages and disadvantages of these compounds
    • Includes the very latest developments, such as photoactivatable and photo-responsive drugs

    Produktinformation

    • Utgivningsdatum:2017-04-11
    • Mått:191 x 235 x 21 mm
    • Vikt:740 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:352
    • Förlag:Elsevier Science
    • ISBN:9780081010112

    Utforska kategorier

    • Farmakologi inom Medicin
    • Kemi inom Naturvetenskap och teknik
    • Organisk kemi inom Naturvetenskap och teknik

    Mer om författaren

    Following a number of years as a medicinal chemistry lecturer and research scientist at institutes including Regensburg University Germany, Queens University Belfast UK, and Harvard Medical School USA, Michael Decker is currently Professor of Pharmaceutical and Medicinal Chemistry at the University Würzburg’s Institute of Pharmacy and Food Chemistry. His predominant focus is on the design of novel therapeutic compounds for the treatment of Alzheimer’s disease, which has led his group to a particular interest in the design of hybrid molecules.Contributor to 75 publications and 1 patent, he is a spokesperson of the International Doctorate Program “Receptor Dynamics: Emerging paradigms for novel drugs” of the “Elite Network of Bavaria” (2014 to 2022) and is very actively engaged with the chemistry community

    Innehållsförteckning

    • 1. Introduction2. Multitarget-Directed Antioxidants as Therapeutic Agents: Putting the Focus on the Oxidative Stress3. Towards Gaseous Mediator Hybrid Drugs4. Designed Hybrid Compounds for Tropical Parasitic Diseases5. Dual-Acting Compounds Acting as Receptor Ligands and Enzyme Inhibitors6. Multitarget Anti-Alzheimer Hybrid Compounds: Do They Work In Vivo?7. Anticancer Hybrids8. Molecular Hybridization: An Emerging Tool for the Design of Novel Therapeutics for Alzheimer’s Disease9. Computational Methods in Multitarget Drug Discovery10. Medicinal Chemistry of Hybrids for Neurodegenerative Diseases11. Photoresponsive Hybrid Compounds